|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
1993-11-24
|
|
pubmed:abstractText |
Three closely related molecular human immunodeficiency virus type 1 (HIV-1) clones, with differential neutralization phenotypes, were generated by cloning of an NcoI-BamHI envelope (env) gene fragment (HXB2R nucleotide positions 5221 to 8021) into the full-length HXB2 molecular clone of HIV-1 IIIB. These env gene fragments, containing the complete gp120 coding region and a major part of gp41, were obtained from three different biological clones derived from a chimpanzee-passaged HIV-1 IIIB isolate. Two of the viruses thus obtained (4.4 and 5.1) were strongly resistant to neutralization by infection-induced chimpanzee and human polyclonal antibodies and by HIV-1 IIIB V3-specific monoclonal antibodies and weakly resistant to soluble CD4 and a CD4-binding-site-specific monoclonal antibody. The third virus (6.8) was sensitive to neutralization by the same reagents. The V3 coding sequence and the gp120 amino acid residues important for the discontinuous neutralization epitope overlapping the CD4-binding site were completely conserved among the clones. However, the neutralization-resistant clones 4.4 and 5.1 differed from neutralization-sensitive clone 6.8 by two mutations in gp41. Exchange experiments confirmed that the 3' end of clone 6.8 (nucleotides 6806 to 8021; amino acids 346 to 752) conferred a neutralization-sensitive phenotype to both of the neutralization-resistant clones 4.4 and 5.1. From our study, we conclude that mutations in the extracellular portion of gp41 may affect neutralization sensitivity to gp120 antibodies.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/8411395-1370558,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8411395-1373549,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8411395-1380099,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8411395-1381908,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8411395-1636088,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8411395-1691208,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8411395-1697332,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8411395-1700004,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8411395-1702301,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8411395-1708933,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8411395-1731110,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8411395-1812947,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8411395-1919529,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8411395-1926772,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8411395-2072448,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8411395-2172833,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8411395-2243375,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8411395-2328092,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8411395-2341832,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8411395-2352323,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8411395-2370681,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8411395-2387997,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8411395-2442411,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8411395-2476484,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8411395-2547987,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8411395-2575137,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8411395-2838179,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8411395-2989706,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8411395-2989707,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8411395-3166553,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8411395-7689324,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8411395-8474172
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0022-538X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
67
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
6897-902
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Mutations in human immunodeficiency virus type 1 gp41 affect sensitivity to neutralization by gp120 antibodies.
|
|
pubmed:affiliation |
Department of Virology, Academic Medical Center, Amsterdam, The Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
